StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$25.13+0.92 (+3.80%)

Close on Nov 18, 2026Market cap $691.46MP/E –Yield –

Fulgent Genetics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Fulgent Genetics's market cap was $707.14M on Nov 11, 2026, against $912.66M a year earlier. Over the last 5 years it ranged from $472.12M to $3.00B, with a median of $715.27M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$707.14M-12.8%
2025Dec 31, 2025$810.53M+43.7%
2024Dec 31, 2024$564.02M-35.0%
2023Dec 29, 2023$868.31M-1.8%
2022Dec 30, 2022$883.90M-70.5%
2021Dec 31, 2021$3.00B+147.1%
2020Dec 31, 2020$1.21B+404.1%
2019Dec 31, 2019$240.88M+320.8%
2018Dec 31, 2018$57.24M-26.5%
2017Dec 29, 2017$77.84M-47.6%
2016Dec 30, 2016$148.63M–

More Fulgent Genetics figures

See a number that looks wrong?